Development and Preliminary Testing of a "Papageno"-Story Interview Intervention- Aim 3

April 20, 2026 updated by: Jane Harness, University of Michigan
The purpose of this study is to determine the effects of a short "Papageno story" video of a compilation of interviews on proximal risk factors for suicide. The researchers believe that the intervention may increase protective factors related to suicide.

Study Overview

Status

Completed

Conditions

Detailed Description

Update 4/20/2026: We changed the study design section from "randomized" to "non-randomized" to reflect a change that was brought to our attention. The platform we used for this study did not use a randomizing function, but rather, individuals were presented with surveys on their dashboards. They only became aware of the surveys' content once they clicked the link and began the session. They were not allowed to respond to both the "Papageno" and the active control surveys.

Study Type

Interventional

Enrollment (Actual)

506

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • People who are part of an existing cohort within DesignXM
  • They will also answer yes to the question: "In the past 1 year, have you wished you were dead or wished you could go to sleep and not wake up?"

Exclusion Criteria:

  • No exclusions if all inclusion criteria is met

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Papageno video
The arm will watch a compilation of interviews on proximal risk factors for suicide
The intervention will be a video (14 min 13 sec in length) of a series of clips from the "Papageno" interviews developed during the pilot phase of this project. The decision to combine the videos and shorten the total length of the video was based on the feedback we received during the acceptability and feasibility phase of this study. Interviewees were asked questions about a time in their life when they came close to suicide but found non-suicide alternatives (their "Papageno" story).
Active Comparator: Control video
The arm will watch an educational control video
The control condition will involve viewing a mental health education video (12 min 14 sec in length) created by our team. It is a simple informational video, aimed at psychoeducation about suicide and safety promotion. It includes a list of mental health and crisis resources. Both videos are interview-style.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Suicidal ideation
Time Frame: Immediately before and after watching the video and at 3 months
Assessed with the Abbreviated Reasons For Living- Young Adult Abbreviated (RFL-YA-II) which consists of 24 questions rated on a scale of 1-6. Higher scores indicate greater importance.
Immediately before and after watching the video and at 3 months
Hopelessness
Time Frame: Immediately before and after watching the video and at 3 months
Assessed with the Beck Hopelessness Scale-4 (BHS-4). The BHS-4 assesses participants' sense of hopelessness, including perceptions of whether their personal actions can improve future outcomes. Participants rate 4 items using a 4 point Likert scale (e.g. "My future seems dark to me"). Each question is coded 0 for positive expectations and 1 for negative expectations.
Immediately before and after watching the video and at 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant perceived agency
Time Frame: Immediately before and after watching the video and at 3 months
As measured by the Perceived Control Scale which is a single-item measure of participant perceived control. Participants will rate agreement with the statement, "right now, I feel like things are out of my control" from 0-10 ("not at all" to "a lot").
Immediately before and after watching the video and at 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jane Harness, DO, University of Michigan
  • Principal Investigator: Cheryl King, PhD, University of Michigan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 17, 2025

Primary Completion (Actual)

October 6, 2025

Study Completion (Actual)

October 6, 2025

Study Registration Dates

First Submitted

February 18, 2025

First Submitted That Met QC Criteria

February 18, 2025

First Posted (Actual)

February 24, 2025

Study Record Updates

Last Update Posted (Actual)

April 23, 2026

Last Update Submitted That Met QC Criteria

April 20, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • HUM00266531
  • SRG-1-123-19 (Other Grant/Funding Number: American Foundation for Suicide Prevention)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified individual participant data that underlie the results reported.

IPD Sharing Time Frame

Approximately 5 years following publication.

IPD Sharing Access Criteria

Investigators whose proposed use of the data has been approved by the investigator.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide Prevention

Clinical Trials on Papageno video

Subscribe